Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with TofacitinibSara van Gennep, Geert D’Haens, Aart Mookhoek et al.|Journal of Crohn s and Colitis|2024Cited by 18
P401 Tofacitinib tissue exposure correlates with endoscopic outcomeBram Verstockt, Séverine Vermeire, Dahham Alsoud et al.|Journal of Crohn s and Colitis|2022Cited by 5
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitisBram Verstockt, Séverine Vermeire, Sujay Singh et al.|Journal of Crohn s and Colitis|2025Cited by 5